Century Therapeutics, Inc. — Income Charts
8 quarters of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Revenue, Gross Profit, Operating Income & Net Income
Margin (%)
Operating Expenses
Income Breakdown
Revenue↓-100.0% -$4M
$0
R&D↓-33.0% -$10M
$20M
D&A↑+7.0% +$232K
$4M
Operating Income↓-3.8% -$1M
$-36M
EBITDA↑+7.0% +$232K
$4M
Interest Expense
—
Other Income/Expense↓-52.1% -$2M
$2M
Pretax Income↓-10.2% -$3M
$-34M
Tax Provision↑+118.4% +$2M
$4M
Net Income↓-10.2% -$3M
$-34M
Operating Margin↑+3729.8pts
67.9%
Net Margin↑+3352.2pts
70.1%
Effective Tax Rate↑+0.0pts
0.0%
Deferred Tax Liabilities↓-100.0% -$137K
$0
NOL Carryforwards
$0
ETR (Continuing Operations)↑+2.2pts
0.7%
ETR Federal Statutory↑+0.0pts
21.0%
ETR State + Local (pp)↑+1.9pts
0.8%
ETR Foreign Differential (pp)↑+0.0pts
0.1%
Operating Lease Cost↓-62.1% -$1M
$664K
Revenue YoY Variation↓-1557.1pts
-100.0%
Income YoY Variation↓-6.2pts
-3.8%
Revenue QoQ Variation↓-90.2pts
-100.0%
Income QoQ Variation↓-4.1pts
-4.2%